Site icon OncologyTube

Treatment options for the young CLL patient with deletion 17p: Do they need a different approach?

Earn CME: https://naccme.com/program/7314

In this presentation from the ‘Navigating the Evolving Therapeutic Landscape of CLL: Strategies for the Optimal Application of Emerging Agents and Combinations in Practice symposium, Dr. Neil E. Kay discusses treatment options for young patients with deletion 17p.

© 2018 Imedex, an HMP Company

Advertisement
Exit mobile version